Resultado de búsqueda
James Lo is a physician-scientist, specializing in cardiovascular medicine and directing a basic research lab. The primary focus of the lab is to understand the fundamental molecular mechanisms of cardiometabolic diseases with the ultimate goal of developing novel treatments directed against them.
James Lo is a physician-scientist, specializing in cardiovascular medicine and directing a basic research lab. The primary focus of the lab is to investigate the molecular mechanisms of cardiometabolic diseases with the ultimate goal of developing novel treatments directed against them.
James Lo is a researcher and educator in adipose biology and pancreatic beta cell function in cardiometabolic diseases. He uses various approaches to study how cells and organisms adapt to metabolic stress and develop novel diagnostic tools and treatments.
September 2, 2020. The Lo Lab was awarded a supplemental R01 award from the National Institute of Diabetes and Digestive and Kidney Diseases at the National Institute of Health (NIDDK/NIH) to study the mechanism of hyperglycemia in COVID-19 patients.
James Lo is a cardiologist and immunologist who studies metabolism and adipose tissue at Weill Cornell Medicine. He leads a team of researchers who investigate obesity, diabetes, arrhythmia, and heart failure.
Investigating metabolic pathways in health and disease. The thematic focus of the lab is to understand how cells and organisms adapt to metabolic stress. We use metabolic diseases such as diabetes, obesity, and cardiovascular disease as model systems of metabolic stress.
Dr. James Lo is an associate professor of medicine and a researcher at Weill Cornell Medicine. He studies pancreatic beta cells, diabetes, COVID-19, and inflammation and neurodegenerative disorders.
